Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics
APEN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for APEN is 6.23 -- better than 94.35% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 250.37 for Apollo Endosurgery Inc; that's greater than it is for 99.77% of US stocks.
- The volatility of Apollo Endosurgery Inc's share price is greater than that of 93.14% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Apollo Endosurgery Inc are CCLP, TTI, MAR, KTB, and QTNT.
- APEN's SEC filings can be seen here. And to visit Apollo Endosurgery Inc's official web site, go to www.apolloendo.com.
APEN Stock Price Chart Interactive Chart >
APEN Price/Volume Stats
| Current price | $5.96 | 52-week high | $7.96 |
| Prev. close | $5.72 | 52-week low | $1.25 |
| Day low | $5.71 | Volume | 130,442 |
| Day high | $6.04 | Avg. volume | 782,756 |
| 50-day MA | $5.56 | Dividend yield | N/A |
| 200-day MA | $3.20 | Market Cap | 154.86M |
Apollo Endosurgery, Inc. (APEN) Company Bio
Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.
Latest APEN News From Around the Web
Below are the latest news stories about Apollo Endosurgery Inc that investors may wish to consider to help them evaluate APEN as an investment opportunity.
Apollo Endosurgery Announces Inducement GrantAUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021. |
Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon ProceduresAUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e. |
Apollo Endosurgery to Present at HC Wainwright Global Life Sciences ConferenceAUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will participate in the H. |
38 Stocks Moving in Monday's Pre-Market SessionGainers Apollo Endosurgery, Inc. (NASDAQ: APEN) shares rose 116% to $10.13 in pre-market trading after the company said it received FDA breakthrough device … |
Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASHAUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received a Breakthrough Device Designation from the U. |
APEN Price Returns
| 1-mo | 5.49% |
| 3-mo | 49.00% |
| 6-mo | 244.51% |
| 1-year | 205.64% |
| 3-year | 1.88% |
| 5-year | -69.04% |
| YTD | 75.29% |
| 2020 | 19.30% |
| 2019 | -17.39% |
| 2018 | -38.39% |
| 2017 | -53.95% |
| 2016 | -31.34% |
Continue Researching APEN
Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...